Literature DB >> 4930772

[Cytisine (Tabex) as a pharmaceutical aid in stopping smoking].

G Scharfenberg, S Benndorf, G Kempe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4930772

Source DB:  PubMed          Journal:  Dtsch Gesundheitsw        ISSN： 0012-0219


× No keyword cloud information.
  13 in total

1.  Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.

Authors:  Sheela K Chellappan; Yingxian Xiao; Werner Tueckmantel; Kenneth J Kellar; Alan P Kozikowski
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

Review 2.  [Pharmacotherapeutic treatment strategies for smoking cessation].

Authors:  N Vasic; R C Wolf; N Wolf; B J Connemann; Z Sosic-Vasic
Journal:  Nervenarzt       Date:  2011-11       Impact factor: 1.214

Review 3.  Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions.

Authors:  Dympna Harmey; Patrick R Griffin; Paul J Kenny
Journal:  Nicotine Tob Res       Date:  2012-09-27       Impact factor: 4.244

Review 4.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Nicola Lindson-Hawley; Kyla H Thomas; Thomas R Fanshawe; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-05-09

5.  An uncontrolled trial of cytisine (Tabex) for smoking cessation.

Authors:  Witold Zatonski; Magdalena Cedzynska; Piotr Tutka; Robert West
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

Review 6.  Mechanism-based medication development for the treatment of nicotine dependence.

Authors:  Zheng-xiong Xi; Krista Spiller; Eliot L Gardner
Journal:  Acta Pharmacol Sin       Date:  2009-05-11       Impact factor: 6.150

7.  Preclinical Pharmacology, Efficacy and Safety of Varenicline in Smoking Cessation and Clinical Utility in High Risk Patients.

Authors:  Zheng-Xiong Xi
Journal:  Drug Healthc Patient Saf       Date:  2010-04-01

8.  Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.

Authors:  Natalie Walker; Colin Howe; Chris Bullen; Hayden McRobbie; Marewa Glover; Varsha Parag; Jonathan Williman; Reon Veale; Vili Nosa; Joanne Barnes
Journal:  BMC Public Health       Date:  2011-11-21       Impact factor: 3.295

Review 9.  Smoking cessation therapy with varenicline.

Authors:  Uma M Mohanasundaram; Rajinder Chitkara; Ganesh Krishna
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial.

Authors:  Ryan J Courtney; Hayden McRobbie; Piotr Tutka; Natasha A Weaver; Dennis Petrie; Colin P Mendelsohn; Anthony Shakeshaft; Saki Talukder; Christel Macdonald; Dennis Thomas; Benjamin C H Kwan; Natalie Walker; Coral Gartner; Richard P Mattick; Christine Paul; Stuart G Ferguson; Nicholas A Zwar; Robyn L Richmond; Christopher M Doran; Veronica C Boland; Wayne Hall; Robert West; Michael Farrell
Journal:  JAMA       Date:  2021-07-06       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.